drug · antibody drug conjugate
patient view →datopotamab deruxtecan
pre_registrationupdated 2mo agoby Daiichi Sankyo Co Ltd🔗 ChEMBL
community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
indications
indications
NSCLC
targets
DNA topoisomerase 1Tumor-associated calcium signal transducer 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that